Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics.

Pediatric Neurology
Emily de Los ReyesRaymond Y Wang

Abstract

Neuronal ceroid lipofuscinosis type 2 or CLN2 disease is a rare, autosomal recessive, neurodegenerative lysosomal storage disorder caused by tripeptidyl peptidase 1 deficiency. Cerliponase alfa, a recombinant human tripeptidyl peptidase 1 enzyme, is the first and only approved treatment for CLN2 disease and the first approved enzyme replacement therapy administered via intracerebroventricular infusion. A meeting of health care professionals from US institutions with experience in cerliponase alfa treatment of children with CLN2 disease was held in November 2018. Key common practices were identified, and later refined during the drafting of this article, that facilitate safe chronic administration of cerliponase alfa. Key practices include developing a multidisciplinary team of clinicians, pharmacists, and coordinators, and institution-specific processes. Infection risk may be reduced through strict aseptic techniques and minimizing connections and disconnections during infusion. The impact of intracerebroventricular device design on port needle stability during extended intracerebroventricular infusion is a critical consideration in device selection. Monitoring for central nervous system infection is performed at each patient c...Continue Reading

References

Nov 7, 1968·The New England Journal of Medicine·R A Ratcheson, A K Ommaya
Dec 7, 2013·BioMed Research International·María Eugenia PortilloAndrej Trampuz
Mar 20, 2014·Toxicology and Applied Pharmacology·Brian R VuillemenotCharles A O'Neill
Jan 7, 2015·Turkish Journal of Medical Sciences·Mehmet SorarSerkan Şimşek'
Mar 31, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Giovanni RaffaAntonino Germanò
Apr 9, 2016·Annals of the Royal College of Surgeons of England·B M Davies, H C Patel
Feb 17, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Allan R TunkelJoseph R Zunt
Mar 25, 2017·Pediatric Neurology·Ruth E WilliamsAngela Schulz
Jun 8, 2017·Drugs·Anthony Markham
Apr 25, 2018·The New England Journal of Medicine·Angela SchulzUNKNOWN CLN2 Study Group
May 26, 2018·Molecular Genetics and Metabolism·Irene SlavcManfred Westphal

❮ Previous
Next ❯

Citations

Oct 18, 2020·Pharmaceutics·Mark A BryniarskiMarilyn E Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.